Skip to main content

Abstract

Objective

Most studies on the diagnostic patterns of usage of specialized services for childhood psychiatric and neurodevelopmental disorders have been cross-sectional, and the aim of this study was to provide longitudinal data.

Methods

The Medical Birth Register and the Finnish Hospital Discharge Register were used to study the use of inpatient or public outpatient specialized services for psychiatric and neurodevelopmental disorders between birth and age 14 in 2010 (cumulative incidence) and in year 2010 at age 14 (one-year prevalence) among Finnish children born in 1996 (N=58,538 singleton live births).

Results

The cumulative incidence of specialized service use for any psychiatric or neurodevelopmental disorders between birth and age 14 was 12.9%, and the one-year prevalence in 2010 at 14 years was 4.2%. The cumulative incidence by age 14 was 5.5% for learning and coordination disorders, 2.2% for anxiety disorders, 2.0% for hyperkinetic disorders, 1.7% for conduct disorders, 1.4% for depression, 1.0% for autism spectrum disorders, and .7% for stress and adjustment disorders. Learning and coordination, hyperkinetic, and autism spectrum disorders were more prevalent among boys, were often diagnosed before school age, and had 9%−51% lifetime comorbidity with each other. Depressive, anxiety, and stress and adjustment disorders had similar distributions between the sexes, were often diagnosed in early adolescence, and showed 8%−31% lifetime comorbidity with each other.

Conclusions

Every eighth Finnish child had visited specialized services for psychiatric or neurodevelopmental disorders sometime between birth and age 14. Learning and coordination disorders were diagnosed more than twice as often as anxiety, hyperkinetic, and conduct disorders.
Less than one-quarter of children with a psychiatric disorder have contact with specialized services (1). Even among adolescents with severe disorders only about half have used mental health services during their lifetime (2). For service system planning, it is important to know the patterns of service use; for example, at what age do children enter the service system, for how long do they use services, what is the sex distribution, what are the common diagnoses, and which diagnoses overlap? However, because of methodological issues, there is a lack of reliable information to answer these questions.
Longitudinal population-based studies of information obtained in interviews have described the longitudinal course of common developmental psychiatric disorders, such as anxiety and conduct disorders (3,4), but their sample sizes were not large enough to study service use of less frequently diagnosed but clinically important disorders, such as autism spectrum disorders. In fact, it has been proposed that an approach other than a survey is needed for studying relatively rare but clinically important disorders (5). Large cross-sectional studies with information from questionnaires or registers can be used when calculating service use prevalence during one year, but when calculating lifetime estimates, longitudinal data sets are preferable to cross-sectional data because of recall bias (6). When studying longitudinal service use patterns, register-based data are especially valuable (7).
Ideally, standardized nationwide register-based longitudinal data from birth are needed to study longitudinal patterns of service use for common and rare disorders. In Finland, all public outpatient and inpatient clinics report standardized person-level data to the nationwide outpatient and inpatient register. These free-of-charge public clinics serve all children who are referred from primary care and who are suspected to have disorders that require diagnostic evaluation or treatment by a specialist and a multiprofessional team. In primary care, medical and psychosocially related health problems should be comprehensively recognized during childhood because all children undergo routine health check-ups performed by a trained nurse at least once a year and by a physician at least six times before the age of two and later at the age of four, seven, 11, and 14 years (8).
A complete nationwide birth cohort was retrieved from the Finnish register of specialized services to overcome the methodological problems with previous studies. In this report, first, the cumulative incidences from birth to age 14 of a wide range of psychiatric and neurodevelopmental disorders are described and compared with cross-sectional one-year prevalence at age 14. Second, sex-specific cumulative incidences of diagnoses in specialized services from birth to age 14 are described. Third, the lifetime comorbidity of disorders diagnosed in specialized services is described.

Methods

Registers and participants

The data were derived from two Finnish health care registers. The number of live-born children was derived from the Medical Birth Register, which is maintained by the National Institute for Health and Welfare and contains information for all births in Finland. Information on the annual incidence of visits to inpatient (1996–2010) and outpatient (1998–2010) units due to psychiatric and neurodevelopmental disorders was derived from the Finnish Hospital Discharge Register (HDR), also maintained by the institute. The register records information on inpatient care in all hospitals and outpatient care in public hospitals, including the child’s personal identification number (PIN), sex, day of admission and discharge, the medical specialty service, and a main diagnosis and secondary diagnosis according to the ICD-10. The diagnoses could be based on any of the main or secondary diagnoses.
All singletons born alive in Finland in 1996 (N=58,538) were included. We chose 1996 because ICD-10 was introduced that year. The outpatient register was established in 1998, but generally, few psychiatric or neurodevelopmental disorders are treated before the age of two (in 1996–1997). Therefore, this discrepancy was not expected to considerably affect the results.
This article describes some of the outcomes in the ongoing FinESSI project (9), but we do not report on assessment of effects of medication use, which is reserved for the FinESSI study. The register administrators and the data protection authority at the National Institute for Health and Welfare approved the use of register data in the FinESSI study (9). The children were not contacted, and informed consent was therefore not required, according to Finnish law. All frequency tabulations were done internally with encrypted PINs at the National Institute for Health and Welfare, and no person-specific data were extracted from the registers.

Diagnostic groups

The following diagnostic groups were included in the study: any psychiatric or neurodevelopmental disorder (ICD-10 codes F00–F99); substance use disorders (F10–F19); nonaffective psychotic disorders (F20–F29, abbreviated to “psychotic disorders”); bipolar disorder (F30–F31); unipolar depression and undefined mood disorders (F32–F39, abbreviated to “depression”); anxiety disorders (F40–F42, F93); stress and adjustment disorders (F43); eating disorders (F50); mental retardation (F70–F79); learning disabilities or motor coordination disorder, including developmental disorders of speech, language, scholastic skills, or motor coordination (F80–F83, abbreviated to “learning and coordination disorders”); pervasive developmental disorders, including autism spectrum disorders (F84); hyperkinetic disorders (F90); conduct disorders, including oppositional defiant disorder (F91, F92); and tic disorders (F95). Lifetime comorbidity, defined as the presence of at least two different diagnostic classes at any time during the follow-up period, was studied between birth and age 14.

Statistical analysis

The follow-up started at birth and ended December 31, 2010, when the participants were 14.0–14.9 years old (born between January 1, 1996, and December 31, 1996). The age of the cohort members was defined as the age on December 31 of the studied year in completed years: the age of 14.0–14.9 years is described as 14 years. One-year prevalence in 2010 was defined as the number of children with visits during 2010, and cumulative incidence was defined as the number of children with an incident diagnosis between birth and 2010. The cumulative incidence of the diagnostic groups was extracted per year of incidence diagnosis and sex from the HDR.

Results

Altogether, 12.9% (N=7,561 of 58,538) of children had used specialized services for psychiatric or neurodevelopmental disorders between birth in 1996 and 2010 (age 14). For a psychiatric or neurodevelopmental disorder, 2,785 children had visited pediatric neurology clinics (cumulative incidence 4.8%), 3,077 had visited child or adolescent psychiatry clinics (cumulative incidence 5.3%), and 2,989 had visited pediatric clinics (cumulative incidence 5.1%). A total of 1,290 children had visited two or more of these specialties (cumulative incidence 2.2%), and 962 had been admitted to a child or adolescent psychiatry inpatient unit (cumulative incidence 1.6%).

Cumulative incidence and one-year-prevalence

Table 1 shows the one-year prevalence in 2010 and the cumulative incidence until 2010 of specialized service use for different diagnostic classes among children born in 1996. The rank order of the cumulative incidence in both sexes by age 14 was learning and coordination disorders (5.5%), anxiety disorders (2.2%), hyperkinetic disorders (2.0%), conduct disorders (1.7%), depression (1.4%), autism spectrum disorders (1.0%), and stress and adjustment disorders (.7%). The cumulative incidence between birth and age 14 was 1.6- to 8.5-fold higher than the one-year prevalence of specialized service use at age 14, depending on the diagnostic group (Table 1). The largest difference between cumulative incidence and one-year prevalence was seen for learning and coordination disorders (5.5% versus .6%). [Some diagnostic groups of special interest listed in Table 1 were analyzed as more specific diagnoses, and these data are presented in an online data supplement to this article.]
Table 1 Specialized service use among all Finnish children born in 1996a
 Boys (N=29,959)Girls (N=28,579)Both sexes (N=58,538)
Specialized service useb1-year prevalence in 2010 (%)Cumulative incidence until 2010 (%)1-year prevalence in 2010 (%)Cumulative incidence until 2010 (%)1-year prevalence in 2010 (%)Cumulative incidence until 2010 (%)
Any psychiatric or neurodevelopmental disorder (F00–F99)4.615.83.99.94.212.9
Learning and coordination disorders (F80–F83).97.7.43.1.65.5
Anxiety disorders (F40–F42, F93).92.21.32.11.12.2
Hyperkinetic disorders (F90)1.23.3.1.6.72.0
Conduct disorders (F91, F92)1.12.4.5.9.81.7
Depression (F32–F39).61.21.31.7.91.4
Autism spectrum disorders (F84).61.5.2.4.41.0
Stress and adjustment disorders (F43).3.7.4.8.4.7
Mental retardation (F70–F79).3.9.2.5.2.7
Tic disorders (F95).2.7<.1.2.1.4
Eating disorders (F50).1.1.4.6.2.4
Substance use disorders (F10–F19).1.2.2.2.1.2
Psychotic disorders (F20–F29).1.2<.1.1.1.1
Bipolar disorder (F30–F31)<.1<.1<.1<.1<.1<.1
a
Children were documented as singleton births and were age 14 in 2010. The diagnostic groups are ranked for both sexes according to the cumulative incidence until 2010.
b
b ICD-10 codes are provided in parentheses.

Cumulative incidence by age

As shown in Figure 1 (panel A), the cumulative incidence of specialized service use for any psychiatric or neurodevelopmental disorder by age 14 was 15.8% among boys and 9.9% among girls. Panels B through H of Figure 1 show the sex-specific cumulative incidence from birth to age 14 for the seven diagnostic groups with the highest cumulative incidence. Boys had higher cumulative incidence than girls with regard to learning and coordination disorders (panel B: boy-to-girl ratio 2.5:1.0), hyperkinetic disorders (D: boy-to-girl ratio 5.5:1.0), conduct disorders (E: boy-to-girl ratio 2.7:1.0), and autism spectrum disorders (G: boy-to-girl ratio 3.8:1.0). The cumulative incidence was similar for boys and girls or slightly higher for girls for anxiety disorders (C), depression (F), and stress and adjustment disorders (H).
Figure 1 The cumulative incidence of specialized service use among children between birth (1996) and age 14 (2010), by sex
The cumulative incidence increased throughout the follow-up for all diagnostic groups shown in Figure 1; that is, new diagnoses were given also at ages 13–14 in all diagnostic groups. However, new diagnoses were typically given before the age of seven for learning and coordination disorders, hyperkinetic disorders, and autism spectrum disorders but after age ten for anxiety disorders, conduct disorders, depression, and stress and adjustment disorders. Further, when the cumulative incidence for childhood autism, Asperger’s syndrome, and pervasive developmental disorder not otherwise specified (PDD-NOS) were analyzed separately, childhood autism was typically diagnosed at an earlier age than Asperger’s syndrome and PDD-NOS. [Cumulative incidence is depicted in a figure in the online data supplement.]

Lifetime comorbidity

Table 2 details the lifetime comorbidity between the seven most common diagnostic groups, shown as the percentage of children with comorbid diagnoses between birth and age 14. Lifetime comorbidity ranged between 2% and 51% across diagnostic combinations, and lifetime comorbidity was present in over 20% of the cases for the following diagnostic groups: hyperkinetic disorders with comorbid learning and coordination disorders, autism spectrum disorders with comorbid learning and coordination disorders or comorbid hyperkinetic disorders, anxiety disorders with comorbid depression, depression with comorbid anxiety disorders, and stress and adjustment disorders with comorbid anxiety disorders or comorbid depression. Lifetime comorbidity of conduct disorders, including oppositional defiant disorder, was present maximally at 11% across diagnostic combinations.
Table 2 Lifetime comorbidity among children in specialized services who were born in 1996 and followed up to 2010a
  Comorbid disorder
  Learning and coordination disordersAnxiety disordersHyperkinetic disordersConduct disordersDepressionAutism spectrum disordersStress and adjustment disorders
Primary disorderTotal NN%N%N%N%N%N%N%
Learning and coordination disorders3,1972517.952116.3902.81243.92889.0621.9
Anxiety disorders1,25925119.913811.0816.425920.6977.7987.8
Hyperkinetic disorders1,15552145.113811.91149.9736.313711.9292.5
Conduct disorders987909.1818.211411.6888.9282.8252.5
Depression84512414.725930.7738.68810.4475.610712.7
Autism spectrum disorders56028851.49717.313724.5285.0478.4122.1
Stress and adjustment disorders4366214.29822.5296.7255.710724.5122.8
a
The percentages indicate the proportion of comorbidity of the diagnostic classes.

Discussion

The diagnostic groups clustered into three groups with regard to the sex distribution, to the age period when the disorders were first diagnosed, and to lifetime comorbidity in specialized care. First, learning and coordination disorders, autism spectrum disorders, and hyperkinetic disorder were more prevalent among boys and were often diagnosed before school age, and the diagnostic groups overlapped to a certain degree. According to a review of sex differences (10), these disorders occur mostly among males and typically involve neurodevelopmental impairment. In fact, they are often termed neurodevelopmental disorders (11). However, the cumulative incidence for these neurodevelopmental disorders continued to increase until the end of follow-up; that is, for many children these disorders were diagnosed in late childhood, although the symptoms per definition must be present before school age. For example, the cumulative incidence of specialized service use for autism spectrum disorders was .5% by age eight and 1.0% by age 14. According to a systematic review from 2012 (12), the prevalence of autism spectrum disorders in recent European studies has ranged between .3% and 1.2%, with a median of .6%. This indicates that a large proportion of Finnish children with autism spectrum disorders sometimes receives a diagnosis in specialized services, but the diagnosis often is established at school age.
Second, conduct disorders, including oppositional defiant disorder, had a male predominance, in line with other studies (10), but were seldom diagnosed before school age and overlapped to a maximum of 11% with the other diagnostic groups. It is notable that the proportion of children with conduct disorder and a comorbid disorder was low compared with the level of comorbidity in population-based surveys (13,14). Although we cannot rule out that hyperkinetic and internalizing disorders are undiagnosed among children with conduct disorder, it is more likely that the low level of comorbidity among children with conduct disorders relates to the diagnostic classification in ICD-10. There is a specific code for “hyperkinetic disorder associated with conduct disorder” (F90.1) under the chapter of hyperkinetic disorders (F90) in the ICD-10, and there is a separate group for “mixed disorders of conduct and emotions” (F92). Accordingly, hyperkinetic disorders associated with conduct disorder were classified as hyperkinetic disorders, and mixed disorders of conduct and emotions were classified as conduct disorders.
Third, prevalence of anxiety disorders, depression, and stress and adjustment disorders was relatively equal between boys and girls, and these disorders were often diagnosed in late childhood or early adolescence, with lifetime comorbidity of these disorders present in many cases. In line with a previous review (10), anxiety and depressive disorders had a similar sex distribution in prepubertal years but were more prevalent among females after puberty. Depression and anxiety are often termed emotional disorders, whereas stress and adjustment disorders can involve both emotional and disruptive symptoms. The diagnostic pattern of stress and adjustment disorders resembled the pattern seen mostly with emotional disorders. Some children first received diagnoses of stress and adjustment or anxiety disorders and later received a diagnosis of depression, because there was a high proportion of comorbidity between these disorders and the age at which stress, adjustment, and anxiety disorders were diagnosed was earlier than the age for a diagnosis of depression.
Several methodological issues should be considered when comparing the cumulative incidence results with the results from other service use studies. For example, survey-based studies potentially are prone to recall bias, whereas register-based studies are not; register-based studies include only specified services, whereas surveys can collect information for different forms of service; and some registers allow for long-term follow-up at the individual level, whereas other registers do not. A novel finding was that 8% of boys and 3% of girls had used specialized services for learning and coordination disorders between birth and age 14, when the data were treated as longitudinal data, but the corresponding proportion was only .9% for boys and .4% for girls when the register-based data were treated as cross-sectional data at age 14. This difference indicates that most Finnish children with learning and coordination disorders visited specialized care only for a short time and that long-term follow-up designs are necessary for identifying these disorders in register-based research. The longitudinal cumulative incidence estimates of learning and coordination disorders, rather than the cross-sectional one-year prevalence, resemble results from surveys. For example, in a cross-sectional U.S. survey from 1997 to 2008 (15), teachers or health professionals had identified 9% and 5% of three- to 17-year-old boys and girls, respectively, with learning disabilities. Future studies with both survey-based and register-based information are needed to investigate to what extent these kinds of information differ.
The cumulative incidence of specialized service use for conduct disorders, including oppositional defiant disorder, was 1.7% by age 14. The comparison with community-based samples is challenging because of methodological issues, but this figure can be considered low. For example, the three-month prevalence of conduct disorder and oppositional defiant disorder among Finnish eight- to nine-year-old children was 5% in a study based on parental interviews (16), and similar figures have been found in the United Kingdom (17) and the United States (18). Similarly, anxiety disorders in specialized care had a cumulative incidence of 2.2% by age 14, whereas the three-month prevalence of anxiety was 5% at age eight in a sample of Finnish children, including children who received treatment and children who did not (16). In line with previous studies (1,2), this difference indicates that in Finland some psychiatric problems, such as conduct and anxiety disorders, are underrecognized in primary care or are not referred to specialized services.
It is well known that neurodevelopmental disorders occur more often among boys than girls, because of different risk and protective factors between the sexes (10). It is also acknowledged that the sex ratio for service use for disorders might be even higher than the sex ratio for the disorders per se (10). As when comparing cumulative incidence with other studies, comparing sex ratios with other studies is challenging because of methodological differences. For example, the boy-girl ratio for autism spectrum disorders was 3.8:1.0 in our study, compared with 2.5:1.0 in a recent epidemiological study from South Korea (19) and 3.9:1.0 in another epidemiological study from the United Kingdom (20). The ratio in this study indicates that there was no major gender bias in referral of children with autism spectrum disorders to specialized services in Finland, but studies with more detailed data on nontreated cases are needed to confirm these findings and give insight into possible gender biases of the full spectrum of disorders.
The strengths of this study include total nationwide longitudinal data from birth, both inpatient and outpatient units from all specialties, and a uniform diagnostic system (ICD-10). There are also several limitations to consider. The results represent all children with specialized service use for psychiatric and neurodevelopmental disorders in Finland but lack information about children who are not recognized by primary care and are not referred to specialized services. Having such information would allow more definitive conclusions to be drawn in regard to unmet need of services and under- and overdiagnosis. Furthermore, the data required complete information concerning specialized service use, because data on primary care visits are not yet available for research purposes in Finland. In addition, the diagnostic validity of childhood autism has been assessed and has been found to be high (21), but it is not known how well other disorders correspond to research diagnostic criteria. Moreover, the total sample was based on all singleton live births, but emigration, immigration, and deaths were not taken into account in the analyses. However, mortality is very low, emigration ranges between .1 and .4% per year, and immigration ranges between .3 and .8% per year among Finnish people between birth and age 14 (22). It is therefore unlikely that these factors would substantially affect the results.

Conclusions

Every eighth Finnish child in this study had visited specialized services for psychiatric or neurodevelopmental disorders sometime between birth and age 14. The most common diagnosis was learning and coordination disorders, which were diagnosed more than twice as often as anxiety, hyperkinetic, and conduct disorders. It is also evident that many children received their diagnosis at a later age than would be expected from what is known about the typical age of symptom onset. One way to improve the early recognition of childhood psychiatric and neurodevelopmental disorders in the population is to implement systematic screening of mental health problems in child welfare and school health clinics. Such an arrangement would be in line with the systematic assessment and referral policies of, for example, scoliosis and deviant growth patterns during childhood (23). However, this would require children with unmet needs to have access to effective mental health interventions, which currently are mainly available in specialized services. The long-term burden of childhood mental health problems is likely to remain high if only a proportion of children with problems access appropriate treatment. Therefore, early identification and a smooth referral system are important to decrease the long-term burden of these problems in the population. Other important ways to promote mental health in childhood and adolescence include educational programs in school settings to increase the knowledge concerning mental health, pathways to care and stigma (24), and easily accessible interventions in primary care.

Acknowledgments and disclosures

This study was funded by National Institutes of Health grant P50MH090966 (Project 1, Dr. Brown and Dr. Sourander, co–principal investigators) and by the Sackler Center for Developmental Psychobiology at Columbia University. Dr. Gyllenberg was funded by the Sigrid Juselius Foundation, by the Finnish Medical Association, and by the Foundation for Pediatric Research in Finland.
The authors report no competing interests.

Supplementary Material

Supplementary Material (367_ds001.pdf)

References

1.
Sayal K: Annotation: Pathways to care for children with mental health problems. Journal of Child Psychology and Psychiatry, and Allied Disciplines 47:649–659, 2006
2.
Merikangas KR, He JP, Burstein M, et al.: Service utilization for lifetime mental disorders in US adolescents: results of the National Comorbidity Survey–Adolescent Supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry 50:32–45, 2011
3.
Moffitt TE, Caspi A, Taylor A, et al.: How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychological Medicine 40:899–909, 2010
4.
Copeland W, Shanahan L, Costello EJ, et al.: Cumulative prevalence of psychiatric disorders by young adulthood: a prospective cohort analysis from the Great Smoky Mountains Study. Journal of the American Academy of Child and Adolescent Psychiatry 50:252–261, 2011
5.
Ford T: Practitioner review: how can epidemiology help us plan and deliver effective child and adolescent mental health services? Journal of Child Psychology and Psychiatry, and Allied Disciplines 49:900–914, 2008
6.
Susser E, Shrout PE: Two plus two equals three? Do we need to rethink lifetime prevalence? Psychological Medicine 40:895–897, 2010
7.
Wierdsma AI, Sytema S, van Os JJ, et al.: Case registers in psychiatry: do they still have a role for research and service monitoring? Current Opinion in Psychiatry 21:379–384, 2008
8.
Decree 338/2011 on Welfare Clinic Services, School and Student Health Services, and Preventive Oral Health Services for Children and Youth [in Finnish]. Helsinki, Government of Finland, 2011
9.
Malm H, Artama M, Brown AS, et al.: Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI). BMC Psychiatry 12:217, 2012
10.
Rutter M, Caspi A, Moffitt TE: Using sex differences in psychopathology to study causal mechanisms: unifying issues and research strategies. Journal of Child Psychology and Psychiatry, and Allied Disciplines 44:1092–1115, 2003
11.
Rutter M, Kim-Cohen J, Maughan B: Continuities and discontinuities in psychopathology between childhood and adult life. Journal of Child Psychology and Psychiatry, and Allied Disciplines 47:276–295, 2006
12.
Elsabbagh M, Divan G, Koh YJ, et al.: Global prevalence of autism and other pervasive developmental disorders. Autism Research 5:160–179, 2012
13.
Angold A, Costello EJ, Erkanli A: Comorbidity. Journal of Child Psychology and Psychiatry, and Allied Disciplines 40:57–87, 1999
14.
Loeber R, Burke JD, Lahey BB, et al.: Oppositional defiant and conduct disorder: a review of the past 10 years, part I. Journal of the American Academy of Child and Adolescent Psychiatry 39:1468–1484, 2000
15.
Boyle CA, Boulet S, Schieve LA, et al.: Trends in the prevalence of developmental disabilities in US children, 1997–2008. Pediatrics 127:1034–1042, 2011
16.
Almqvist F, Puura K, Kumpulainen K, et al.: Psychiatric disorders in 8–9-year-old children based on a diagnostic interview with the parents. European Child and Adolescent Psychiatry 8(suppl 4):17–28, 1999
17.
Ford T, Goodman R, Meltzer H: The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders. Journal of the American Academy of Child and Adolescent Psychiatry 42:1203–1211, 2003
18.
Costello EJ, Mustillo S, Erkanli A, et al.: Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry 60:837–844, 2003
19.
Kim YS, Leventhal BL, Koh YJ, et al.: Prevalence of autism spectrum disorders in a total population sample. American Journal of Psychiatry 168:904–912, 2011
20.
Chakrabarti S, Fombonne E: Pervasive developmental disorders in preschool children. JAMA 285:3093–3099, 2001
21.
Lampi KM, Sourander A, Gissler M, et al.: Validity of Finnish registry-based diagnoses of autism with the ADI-R. Acta Paediatrica 99:1425–1428, 2010
22.
Immigration and Emigration by Age, Sex and Area 1987–2011. Helsinki, Statistics Finland, 2012
23.
Maternity and Child Welfare Clinics, School and Student Health Care and Preventive Oral Health Care [in Finnish]. Helsinki, Ministry of Social Affairs and Health, 2012
24.
Kutcher S, Wei Y: Mental health and the school environment: secondary schools, promotion and pathways to care. Current Opinion in Psychiatry 25:311–316, 2012

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Young Girl Playing, by Jessie Willcox Smith, 1902. Watercolor and charcoal on board. © Copyright 2014 National Museum of American Illustration™, Newport, Rhode Island. Photo courtesy of Archives of the American Illustrators Gallery™, New York.

Psychiatric Services
Pages: 367 - 373
PubMed: 24337256

History

Published in print: March 2014
Published online: 15 October 2014

Authors

Details

David Gyllenberg, M.D., Ph.D.
Dr. Gyllenberg is with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, and the New York State Psychiatric Institute, New York City (e-mail: [email protected]), where Dr. Brown and Dr. Sourander are affiliated. Dr. Gyllenberg and Dr. Sourander are also with the Department of Child Psychiatry, University of Turku and Turku University Central Hospital, Turku, Finland, where Dr. Gissler, Dr. Malm, Dr. Artama, and Ms. Hinkka-Yli-Salomäki are affiliated. Dr. Brown is also at the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City. Dr. Gissler is also with the National Institute for Health and Welfare, Helsinki, Finland. Dr. Malm is also with the Department of Teratology Information, HUSLAB, Helsinki. Dr. Artama is also with the Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki.
Mika Gissler, Ph.D.
Dr. Gyllenberg is with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, and the New York State Psychiatric Institute, New York City (e-mail: [email protected]), where Dr. Brown and Dr. Sourander are affiliated. Dr. Gyllenberg and Dr. Sourander are also with the Department of Child Psychiatry, University of Turku and Turku University Central Hospital, Turku, Finland, where Dr. Gissler, Dr. Malm, Dr. Artama, and Ms. Hinkka-Yli-Salomäki are affiliated. Dr. Brown is also at the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City. Dr. Gissler is also with the National Institute for Health and Welfare, Helsinki, Finland. Dr. Malm is also with the Department of Teratology Information, HUSLAB, Helsinki. Dr. Artama is also with the Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki.
Heli Malm, M.D., Ph.D.
Dr. Gyllenberg is with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, and the New York State Psychiatric Institute, New York City (e-mail: [email protected]), where Dr. Brown and Dr. Sourander are affiliated. Dr. Gyllenberg and Dr. Sourander are also with the Department of Child Psychiatry, University of Turku and Turku University Central Hospital, Turku, Finland, where Dr. Gissler, Dr. Malm, Dr. Artama, and Ms. Hinkka-Yli-Salomäki are affiliated. Dr. Brown is also at the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City. Dr. Gissler is also with the National Institute for Health and Welfare, Helsinki, Finland. Dr. Malm is also with the Department of Teratology Information, HUSLAB, Helsinki. Dr. Artama is also with the Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki.
Miia Artama, Ph.D.
Dr. Gyllenberg is with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, and the New York State Psychiatric Institute, New York City (e-mail: [email protected]), where Dr. Brown and Dr. Sourander are affiliated. Dr. Gyllenberg and Dr. Sourander are also with the Department of Child Psychiatry, University of Turku and Turku University Central Hospital, Turku, Finland, where Dr. Gissler, Dr. Malm, Dr. Artama, and Ms. Hinkka-Yli-Salomäki are affiliated. Dr. Brown is also at the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City. Dr. Gissler is also with the National Institute for Health and Welfare, Helsinki, Finland. Dr. Malm is also with the Department of Teratology Information, HUSLAB, Helsinki. Dr. Artama is also with the Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki.
Susanna Hinkka-Yli-Salomäki, Ph.Lic.
Dr. Gyllenberg is with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, and the New York State Psychiatric Institute, New York City (e-mail: [email protected]), where Dr. Brown and Dr. Sourander are affiliated. Dr. Gyllenberg and Dr. Sourander are also with the Department of Child Psychiatry, University of Turku and Turku University Central Hospital, Turku, Finland, where Dr. Gissler, Dr. Malm, Dr. Artama, and Ms. Hinkka-Yli-Salomäki are affiliated. Dr. Brown is also at the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City. Dr. Gissler is also with the National Institute for Health and Welfare, Helsinki, Finland. Dr. Malm is also with the Department of Teratology Information, HUSLAB, Helsinki. Dr. Artama is also with the Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki.
Alan S. Brown, M.D., M.P.H.
Dr. Gyllenberg is with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, and the New York State Psychiatric Institute, New York City (e-mail: [email protected]), where Dr. Brown and Dr. Sourander are affiliated. Dr. Gyllenberg and Dr. Sourander are also with the Department of Child Psychiatry, University of Turku and Turku University Central Hospital, Turku, Finland, where Dr. Gissler, Dr. Malm, Dr. Artama, and Ms. Hinkka-Yli-Salomäki are affiliated. Dr. Brown is also at the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City. Dr. Gissler is also with the National Institute for Health and Welfare, Helsinki, Finland. Dr. Malm is also with the Department of Teratology Information, HUSLAB, Helsinki. Dr. Artama is also with the Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki.
Andre Sourander, M.D., Ph.D.
Dr. Gyllenberg is with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, and the New York State Psychiatric Institute, New York City (e-mail: [email protected]), where Dr. Brown and Dr. Sourander are affiliated. Dr. Gyllenberg and Dr. Sourander are also with the Department of Child Psychiatry, University of Turku and Turku University Central Hospital, Turku, Finland, where Dr. Gissler, Dr. Malm, Dr. Artama, and Ms. Hinkka-Yli-Salomäki are affiliated. Dr. Brown is also at the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City. Dr. Gissler is also with the National Institute for Health and Welfare, Helsinki, Finland. Dr. Malm is also with the Department of Teratology Information, HUSLAB, Helsinki. Dr. Artama is also with the Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share